TY  - JOUR
AU  - Mateos, María-Victoria
AU  - Martínez-López, Joaquin
AU  - Rodriguez Otero, Paula
AU  - González-Calle, Verónica
AU  - Gonzalez, Marta Sonia
AU  - Oriol, Albert
AU  - Gutiérrez, Norma C
AU  - Ríos-Tamayo, Rafael
AU  - Rosiñol, Laura
AU  - Alvarez Rivas, Miguel Angel
AU  - Bargay Lleonart, Joan
AU  - Gonzalez-Rodriguez, Ana Pilar
AU  - Alegre, Adrián
AU  - Escalante, Fernando
AU  - Iñigo Rodríguez, María Belén
AU  - de la Rubia, Javier
AU  - Teruel, Ana Isabel
AU  - de Arriba, Felipe
AU  - Palomera, Luis
AU  - Hernández, Miguel T
AU  - Lopez Jiménez, Javier
AU  - Reinoso-Segura, Marta
AU  - García Mateo, Aránzazu
AU  - Ocio, Enrique M
AU  - Paiva, Bruno
AU  - Puig, Noemi
AU  - Cedena, Maria Teresa
AU  - Bladé, Joan
AU  - Lahuerta, Juan Jose
AU  - San-Miguel, Jesus F
PY  - 2024
DO  - 10.1200/JCO.23.02771
UR  - https://hdl.handle.net/20.500.13003/21129
T2  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
AB  - Early treatment of high-risk smoldering myeloma has been shown to delay progression to multiple myeloma (MM). We conducted this trial with curative intention using a treatment approach employed for newly diagnosed patients with MM.Patients with...
LA  - eng
M2  - 3247
PB  - ASCO Publications
KW  - Disease Progression
KW  - Aged
KW  - Hematopoietic Stem Cell Transplantation
KW  - Adult
KW  - Transplantation, Autologous
KW  - Humans
KW  - Melphalan
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Smoldering Multiple Myeloma
KW  - Middle Aged
KW  - Oligopeptides
KW  - Consolidation Chemotherapy
KW  - Lenalidomide
KW  - Male
KW  - Multiple Myeloma
KW  - Maintenance Chemotherapy
KW  - Female
KW  - Dexamethasone
TI  - Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance
TY  - research article
VL  - 42
ER  -